Noninvasive prenatal diagnosis (NIPD) of non-syndromic hearing loss (NSHL) for singleton and twin pregnancies in the first trimester

Abstract Background Noninvasive prenatal diagnosis (NIPD) has been proven feasible for non-syndromic hearing loss (NSHL) in singleton pregnancies. However, previous research is limited to the second trimester and the application in twin pregnancies is blank. Here we provide a novel algorithmic appro...

Full description

Saved in:
Bibliographic Details
Main Authors: Huanyun Li, Shaojun Li, Zhenhua Zhao, Lingrong Kong, Xinyu Fu, Jingqi Zhu, Jun Feng, Weiqin Tang, Di Wu, Xiangdong Kong
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Orphanet Journal of Rare Diseases
Subjects:
Online Access:https://doi.org/10.1186/s13023-025-03558-x
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832571323723808768
author Huanyun Li
Shaojun Li
Zhenhua Zhao
Lingrong Kong
Xinyu Fu
Jingqi Zhu
Jun Feng
Weiqin Tang
Di Wu
Xiangdong Kong
author_facet Huanyun Li
Shaojun Li
Zhenhua Zhao
Lingrong Kong
Xinyu Fu
Jingqi Zhu
Jun Feng
Weiqin Tang
Di Wu
Xiangdong Kong
author_sort Huanyun Li
collection DOAJ
description Abstract Background Noninvasive prenatal diagnosis (NIPD) has been proven feasible for non-syndromic hearing loss (NSHL) in singleton pregnancies. However, previous research is limited to the second trimester and the application in twin pregnancies is blank. Here we provide a novel algorithmic approach to assess singleton and twin pregnancies in the first trimester. Methods A 324.614 kb capture panel was designed to selectively enrich target regions. Parental haplotypes were constructed by target sequencing of blood samples from the parents and the proband. Then single nucleotide polymorphisms (SNP) within target regions were classified into four and six categories in singleton and twin pregnancy, respectively. Combining relative haplotype dosage change (RHDO) and the Bayes factor (BF), fetal fraction (FF) and fetal genotype were deduced in singleton and twin pregnancies. The pregnant women’s NIPD results were validated by invasive prenatal diagnosis and Sanger sequencing. Results Sixteen women with singleton pregnancies and one woman with a twin pregnancy were recruited. Among the 16 singleton pregnancies, NIPD was successfully applied in 15 families and the coincidence rate with invasive prenatal diagnosis was 100% (15/15). Only one family NIPD result is “no call” because the imbalance distribution of SNP sites makes it difficult to estimate recombination events. Most (13/15) of pregnant women were diagnosed in the first trimester and the earliest gestation week was the 7th week. The twin pregnancy was a dichorionic diamniotic twin (DCDA). NIPD confirmed one fetus is affected, and another is a carrier with c.299_300delAT of GJB2 gene. Conclusion This study represents the pioneering evidence in the field, demonstrating the feasibility of NIPD for NSHL in twin pregnancies. Moreover, it provides a novel and advanced diagnostic approach for families at high risk of NSHL during pregnancy, offering earlier detection, enhanced safety, and improved accuracy.
format Article
id doaj-art-afa032777a7c4edba0a613cfb14ba337
institution Kabale University
issn 1750-1172
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series Orphanet Journal of Rare Diseases
spelling doaj-art-afa032777a7c4edba0a613cfb14ba3372025-02-02T12:42:21ZengBMCOrphanet Journal of Rare Diseases1750-11722025-01-012011910.1186/s13023-025-03558-xNoninvasive prenatal diagnosis (NIPD) of non-syndromic hearing loss (NSHL) for singleton and twin pregnancies in the first trimesterHuanyun Li0Shaojun Li1Zhenhua Zhao2Lingrong Kong3Xinyu Fu4Jingqi Zhu5Jun Feng6Weiqin Tang7Di Wu8Xiangdong Kong9Genetic and Prenatal Diagnosis Center, Department of Obstetrics and Gynecology, The First Affiliated Hospital of Zhengzhou UniversityCelula (China) Medical Technology Co., Ltd.Genetic and Prenatal Diagnosis Center, Department of Obstetrics and Gynecology, The First Affiliated Hospital of Zhengzhou UniversityGenetic and Prenatal Diagnosis Center, Department of Obstetrics and Gynecology, The First Affiliated Hospital of Zhengzhou UniversityGenetic and Prenatal Diagnosis Center, Department of Obstetrics and Gynecology, The First Affiliated Hospital of Zhengzhou UniversityGenetic and Prenatal Diagnosis Center, Department of Obstetrics and Gynecology, The First Affiliated Hospital of Zhengzhou UniversityCelula (China) Medical Technology Co., Ltd.Celula (China) Medical Technology Co., Ltd.Celula (China) Medical Technology Co., Ltd.Genetic and Prenatal Diagnosis Center, Department of Obstetrics and Gynecology, The First Affiliated Hospital of Zhengzhou UniversityAbstract Background Noninvasive prenatal diagnosis (NIPD) has been proven feasible for non-syndromic hearing loss (NSHL) in singleton pregnancies. However, previous research is limited to the second trimester and the application in twin pregnancies is blank. Here we provide a novel algorithmic approach to assess singleton and twin pregnancies in the first trimester. Methods A 324.614 kb capture panel was designed to selectively enrich target regions. Parental haplotypes were constructed by target sequencing of blood samples from the parents and the proband. Then single nucleotide polymorphisms (SNP) within target regions were classified into four and six categories in singleton and twin pregnancy, respectively. Combining relative haplotype dosage change (RHDO) and the Bayes factor (BF), fetal fraction (FF) and fetal genotype were deduced in singleton and twin pregnancies. The pregnant women’s NIPD results were validated by invasive prenatal diagnosis and Sanger sequencing. Results Sixteen women with singleton pregnancies and one woman with a twin pregnancy were recruited. Among the 16 singleton pregnancies, NIPD was successfully applied in 15 families and the coincidence rate with invasive prenatal diagnosis was 100% (15/15). Only one family NIPD result is “no call” because the imbalance distribution of SNP sites makes it difficult to estimate recombination events. Most (13/15) of pregnant women were diagnosed in the first trimester and the earliest gestation week was the 7th week. The twin pregnancy was a dichorionic diamniotic twin (DCDA). NIPD confirmed one fetus is affected, and another is a carrier with c.299_300delAT of GJB2 gene. Conclusion This study represents the pioneering evidence in the field, demonstrating the feasibility of NIPD for NSHL in twin pregnancies. Moreover, it provides a novel and advanced diagnostic approach for families at high risk of NSHL during pregnancy, offering earlier detection, enhanced safety, and improved accuracy.https://doi.org/10.1186/s13023-025-03558-xNoninvasive prenatal diagnosisNon-syndromic hearing lossHaplotype constructionBayes factorsTwin
spellingShingle Huanyun Li
Shaojun Li
Zhenhua Zhao
Lingrong Kong
Xinyu Fu
Jingqi Zhu
Jun Feng
Weiqin Tang
Di Wu
Xiangdong Kong
Noninvasive prenatal diagnosis (NIPD) of non-syndromic hearing loss (NSHL) for singleton and twin pregnancies in the first trimester
Orphanet Journal of Rare Diseases
Noninvasive prenatal diagnosis
Non-syndromic hearing loss
Haplotype construction
Bayes factors
Twin
title Noninvasive prenatal diagnosis (NIPD) of non-syndromic hearing loss (NSHL) for singleton and twin pregnancies in the first trimester
title_full Noninvasive prenatal diagnosis (NIPD) of non-syndromic hearing loss (NSHL) for singleton and twin pregnancies in the first trimester
title_fullStr Noninvasive prenatal diagnosis (NIPD) of non-syndromic hearing loss (NSHL) for singleton and twin pregnancies in the first trimester
title_full_unstemmed Noninvasive prenatal diagnosis (NIPD) of non-syndromic hearing loss (NSHL) for singleton and twin pregnancies in the first trimester
title_short Noninvasive prenatal diagnosis (NIPD) of non-syndromic hearing loss (NSHL) for singleton and twin pregnancies in the first trimester
title_sort noninvasive prenatal diagnosis nipd of non syndromic hearing loss nshl for singleton and twin pregnancies in the first trimester
topic Noninvasive prenatal diagnosis
Non-syndromic hearing loss
Haplotype construction
Bayes factors
Twin
url https://doi.org/10.1186/s13023-025-03558-x
work_keys_str_mv AT huanyunli noninvasiveprenataldiagnosisnipdofnonsyndromichearinglossnshlforsingletonandtwinpregnanciesinthefirsttrimester
AT shaojunli noninvasiveprenataldiagnosisnipdofnonsyndromichearinglossnshlforsingletonandtwinpregnanciesinthefirsttrimester
AT zhenhuazhao noninvasiveprenataldiagnosisnipdofnonsyndromichearinglossnshlforsingletonandtwinpregnanciesinthefirsttrimester
AT lingrongkong noninvasiveprenataldiagnosisnipdofnonsyndromichearinglossnshlforsingletonandtwinpregnanciesinthefirsttrimester
AT xinyufu noninvasiveprenataldiagnosisnipdofnonsyndromichearinglossnshlforsingletonandtwinpregnanciesinthefirsttrimester
AT jingqizhu noninvasiveprenataldiagnosisnipdofnonsyndromichearinglossnshlforsingletonandtwinpregnanciesinthefirsttrimester
AT junfeng noninvasiveprenataldiagnosisnipdofnonsyndromichearinglossnshlforsingletonandtwinpregnanciesinthefirsttrimester
AT weiqintang noninvasiveprenataldiagnosisnipdofnonsyndromichearinglossnshlforsingletonandtwinpregnanciesinthefirsttrimester
AT diwu noninvasiveprenataldiagnosisnipdofnonsyndromichearinglossnshlforsingletonandtwinpregnanciesinthefirsttrimester
AT xiangdongkong noninvasiveprenataldiagnosisnipdofnonsyndromichearinglossnshlforsingletonandtwinpregnanciesinthefirsttrimester